Early Diagnosis-related Imaging Biomarker Detection Service
As an expert in the field of biomarkers, Creative BioMart Biomarker provides a variety of scientific research outsourcing services related to imaging biomarkers, including early diagnosis-related imaging biomarker detection service, which helps customers advance research projects in the field of early diagnosis. In addition, we also provide imaging biomarker detection services related to disease risk evaluation, disease staging and prognosis evaluation. We have an advanced imaging technology platform and a professional technical team, with the ability to provide customers with high-quality and professional technical services.
Introduction
Early diagnosis of the disease has always been the focus of clinical research, because discovering the disease in the early stages can provide patients with more treatment options, increase the chance of successful treatment, and avoid the consequences of treatment delays that endanger the safety of patients. For diseases caused by Alzheimer's disease and some other dementias, early diagnosis is essential. Patients have certain cognitive ability in the early stage of these diseases, which can better assist doctors in the treatment process and reduce the symptoms of these diseases through treatment. For cancer, its early diagnosis means that it can make the best treatment choices, improve the condition of the disease through early treatment and care, avoid the occurrence of tumor metastasis, and increase the survival time of patients. Due to the lack of specific symptoms in the early stages of some diseases, it is not conducive to the early detection of these diseases, which often leads to delayed treatment of these diseases and reduces the survival rate of patients. For example, cancer is generally difficult to detect at an early stage. Many cancer patients are diagnosed with cancer in the middle and advanced stages, and often miss the best opportunity for treatment. Imaging technology has always been an effective measure for early diagnosis. For example, ultrasound contrast, dynamic contrast enhanced computed tomography and magnetic resonance imaging have an important position in the early diagnosis and disease monitoring of hepatocellular carcinoma. In addition, imaging biomarkers have also been studied in the early diagnosis of Alzheimer's disease, pancreatitis, and osteoarthritis. Therefore, imaging biomarkers have huge development potential and broad research prospects in the early diagnosis.
Application
Early diagnosis-related imaging biomarker detection service is suitable for the research of various diseases, including breast cancer, osteoarthritis, cardiovascular disease, Alzheimer's disease, etc.
Our Imaging Biomarker Detection Services Related to Early Diagnosis:
- Early Diagnosis of Lung Cancer
- Early Diagnosis of Parkinson's Disease
- Early Diagnosis of Renal Osteodystrophy
- Early Diagnosis of Asthma
- Early Diagnosis of Hepatobiliary Disease
- Early Diagnosis of Prostate Cancer
- Early Diagnosis of Obesity
- Early Diagnosis of Brain-Related Disease
- Early Diagnosis of Degenerative Change
Our Advantages
- Multiple imaging biomarkers detection technology platforms
- Ensure high accuracy and precision imaging biomarkers detection service
- Provide quantitative imaging biomarkers detection service
- Provide detailed professional analysis report
- Customized service scheme according to the specific needs
- Shorter service cycle and more competitive prices
- Experienced technical team
Workflow of Imaging Biomarker Detection at Creative BioMart Biomarker
At Creative BioMart Biomarker, we provide customers with high-quality imaging biomarker detection services related to early diagnosis. Customers can discuss with our expert team based on specific research needs or research objects, and we will work out the appropriate experimental plan as soon as possible. Our technical team has extensive experience in the field of imaging biomarkers, and has been strictly controlling every process in the imaging biomarker detection service to ensure that customers are provided with accurate test results. If you are seeking related services, Creative BioMart Biomarker may be your ideal choice, please feel free to contact us for more information.
References:
- Balaceanu, L. A. Biomarkers vs imaging in the early detection of hepatocellular carcinoma and prognosis. World Journal of Clinical Cases. 2019, 7(12): 1367-1382.
- Salvatore, C.; et al. Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach. Frontiers in Neuroscience. 2015, 9: 307
